Alloy vs TeleHealth Med
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alloy
Best for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directoryStarting at $80/mo
TeleHealth Med
Best for Buyers seeking a Georgia-based, Inc.-incorporated telehealth platform with LegitScript verification, explicit 503A pharmacy designation, verbatim FDA compounded disclaimer, and honest testimonial-compensation disclosure — strong fit for transparency-conscious cash-pay patients who want HSA/FSA acceptance and both injectable and sublingual GLP-1 form options.Starting at $147/mo
Side-by-Side Comparison
| Feature | Alloy | TeleHealth Med |
|---|---|---|
| Overall Score | ✓7.4/10 | 6.8/10 |
| Starting Price | ✓$80/mo | $147/mo |
| Editorial Rating | ✓3.7 ★ /5 | 3.4 ★ /5 |
| Features | 8 features | ✓14 features |
| States Available | 0 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | ✓ Yes |
| FDA Warnings | None | None |
Pros & Cons
Alloy
Pros
- ✓Broadest GLP-1 formulary in our catalog: brand Wegovy + brand Zepbound + oral Wegovy + compounded semaglutide + compounded tirzepatide + compounded liraglutide
- ✓All consulting doctors are certified by The Menopause Society — only ~1,000 such certified practitioners exist among ~20,000 OB-GYNs in the US
- ✓Brand-name Wegovy starting at $199/mo and compounded liraglutide starting at $80/mo cover both ends of the price/access spectrum
- ✓STARTGLP1 promo code knocks $50 off the first month per the public site
Cons
- ✗Not available in Louisiana or Mississippi (verified) — readers in those two states should be routed elsewhere
- ✗Initial consultation is $49 and is separate from medication cost — readers should know there's a non-refundable upfront fee
- ✗Menopause-specialty framing — best fit for women in menopause/perimenopause, not the right product for men or younger women whose primary need is weight loss
TeleHealth Med
Pros
- ✓Corporate Inc. entity explicitly disclosed (TeleHealth Med, Inc.) — clearer accountability than LLC-or-undisclosed competitors
- ✓Verbatim FDA compounded-medication disclaimer published — meets WLR transparency standard
- ✓503A pharmacy designation explicitly stated in FAQ (verbatim)
- ✓**Honest testimonial-compensation disclosure** — verbatim 'Testimonials are compensated. Customer images are user-submitted, and individual results have not undergone independent verification.' Uncommon honest framing vs DTC competitors that present testimonials as organic
- ✓Both injectable AND sublingual forms offered (per FAQ — auto-classifies into /best/oral-glp1-providers via description regex)
- ✓HSA / FSA accepted — uncommon in DTC compounded-GLP-1 market
- ✓Phone support published (1-833-865-8118) with business-hours coverage
- ✓LegitScript verification link active
- ✓$147/mo entry pricing is competitive with the DTC market
Cons
- ✗Specific 503A pharmacy partner NOT named (only generic '503A pharmacies' framing)
- ✗LegitScript ID NUMBER not visible in text form (only the verification link)
- ✗Full states-served list NOT explicitly disclosed — footer references CA/MA/RI/VT for license-verification resources but these are not framed as the exhaustive states-served list
- ✗Named medical director / clinical leadership NOT disclosed
- ✗Affiliate tracking uses panoramatrack.com (NOT the standard Katalys/RevOffers pattern other WLR providers use)
- ✗Pricing dose tiers beyond starting $147/mo NOT disclosed publicly
- ✗Refund policy partially restrictive — 'no refunds for partially utilized subscription periods or bundled packages'; 'Refunds for canceled services may be proportionally adjusted if initial promotional discounts'
- ✗Compounded-tirzepatide pricing NOT explicitly stated on homepage (only main heading lists 'GLP-1, Semaglutide & Tirzepatide')
- ✗Site disclaims being a pharmacy or healthcare provider — common DTC framing but worth noting for accountability-conscious buyers
- ✗'100,000+ treatments' + '98% achievement rate' claims not independently verified
Our Verdict
Alloy edges out TeleHealth Med with a higher overall score of 7.4/10 and is particularly strong for women in menopause/perimenopause who want a Menopause Society-certified clinician AND the broadest brand+compounded GLP-1 formulary in our directory. TeleHealth Med remains a solid alternative, especially if you're looking for Buyers seeking a Georgia-based, Inc.-incorporated telehealth platform with LegitScript verification, explicit 503A pharmacy designation, verbatim FDA compounded disclaimer, and honest testimonial-compensation disclosure — strong fit for transparency-conscious cash-pay patients who want HSA/FSA acceptance and both injectable and sublingual GLP-1 form options..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.